The vitamin D market driven by growth in awareness of vitamin D deficiency, a rise in incidences of osteoporosis in women, & an increase in cases of malnutrition in children. Rising number of government initiatives & awareness campaigns is expected to create new growth opportunities for growth of vitamin D market.
The vitamin D market is estimated at USD 1.1 billion in 2019 and projected to grow at a CAGR of 7.0%, to reach USD 1.7 billion by 2025. The scarcity of ingredients, coupled with the high cost, are the major restraints of the market. There are very few natural foods that provide vitamin D, increasing the risk of deficiency of vitamin D among the consumers. Based on end user, the children segment is estimated to be the fastest-growing during the forecast period.Rickets is a disease mostly found in children, caused due to a deficiency of vitamin D.
Download Free Sample PDF of Vitamin D Market Study With 171 Pages and 12 Company Profiles Now at https://www.reportsnreports.com/contacts/requestsample.aspx?name=402132 .
Vitamin D and several other vitamins face the problem of raw material unavailability, as a result of which there is an increase in the price. This high price stands to be one of the biggest challenges for the growth of sales of vitamins. Infants who are exclusively breastfed do not receive daily vitamin D supplements and are at the greatest risk for rickets.
“The children segment for vitamin D is estimated to be the fastest growing segment of the vitamin D market.”
Vitamin D helps ensure that the body absorbs and retains calcium and phosphorus, both critical for building bone tissue. Vitamin D deficiency can lead to rickets, which continues to be reported in the US, mostly in children in the first two years of life. Based on IU strength, the 40 MIU segment is projected to be the fastest-growing during the forecast period. Vitamin D3 40 MIU is also referred to as “vitamin D3 crystalline” and has a potency of 40 million international units per gram, the highest potency of vitamin D3. The product is majorly a white crystalline powder.
Make an Inquiry for Discount on Vitamin D Market Research Now Available at https://www.reportsnreports.com/contacts/discount.aspx?name=402132 .
Vitamin D3 of 500,000 IU is a free-flowing powder form of vitamin D3, which has a potency of 500,000 IU/gram and is practically insoluble in water. The vitamin D of 500,000 IU is majorly consumed in feed products. The 40 MIU type has a wide application in the pharmaceuticals segment and is therefore projected to grow at the highest rate during the forecast period.
Key players in vitamin D market include Zhejiang Garden Biochemical High-Tech Co.,Ltd (China), Koninklijke DSM N.V. (Netherlands), Zhejiang Xinhecheng Co., Ltd. (China), Taizhou Haisheng Pharmaceutical Co., Ltd. (China), Xiamen Jindawei Vitamin Co., Ltd. (China), Fermenta Biotech Ltd. (India), Zhejiang Medicine Co., Ltd.(China), BASF (Germany), and Dishman Group (India).
- In January 2019, Zhejiang Xinhecheng Co., Ltd. (China) and DSM (Netherlands) signed an agreement for the sale and purchase of cholesterol. Cholesterol is used to produce vitamin D3. This agreement would help the company to increase its overall capacity and productivity of Vitamin D.
- In January 2019, Fermenta Biotech Limited (India) executed a 99-year lease agreement to acquire a land of about 40,000-square-meter from the Gujarat Industrial Development Corporation (GIDC) authority, Ankleshwar, Sayakha, for future expansion. The company aims to commence manufacturing by the end of 2020.
- In April 2016, Xiamen Jindawei Vitamin Co., Ltd., and Wu Kun Health Food Co., Ltd. (Japan) entered into a joint venture. This deal helped the company to expand its business in Japan.
More Details on “Vitamin D Market by Analog (Vitamin D2, Vitamin D3), Form (Dry, Liquid), Application (Functional Food & Beverage, Pharma, Feed, and Personal Care), End User (Children, Adult, and Pregnant Women), Iu Strength and Region – Global Forecast to 2025” Research at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=402132 .
China and India are two of the most favorable markets for vitamin D manufacturers for expansion, due to the rising demand for animal feed, fortified food products, and easy availability of raw materials. It has become a key destination for manufacturers of vitamin D supplements and pharmaceutical product companies such as the Alkem Laboratories (India), Cadila Pharmaceuticals (India), Abbott Laboratories (US), and Sanofi S.A (France).
Key Benefits to Buy the Report
The report segments the vitamin D market on the basis of analog, IU strength, form, application, end user, and region. In terms of insights, this report has focused on various levels of analyses—competitive landscape, end-use analysis, and company profiles—which together comprise and discuss views on the emerging & high-growth segments of the global vitamin D, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges.